RSSS stock news
This page provides real-time market news, earnings updates, and company announcements related to Research Solutions, Inc (RSSS).
All content is aggregated from trusted financial media and market data sources to help investors stay informed about key market movements and corporate developments.
Last updated as of 2026-03-02 08:32 EST
Ocugen Announces Phase 3 liMeliGhT Enrollment Completion for OCU400, a Novel Modifier Gene Therapy for Broad Retinitis Pigmentosa
Finviz2026-03-02 12:06:36
Venture Global: Fourth Quarter Financial Overview
101 finance2026-03-02 12:12:15
Typical Stock Portfolio Patterns for Individuals in Their
101 finance2026-03-02 12:15:44
Xeris Bi
101 finance2026-03-02 12:18:16
Is Xtrackers Russell US Multifactor ETF (DEUS) Currently a Top ETF Choice?
101 finance2026-03-02 12:24:41
Is First Trust Multi Cap Growth AlphaDEX ETF (FAD) Currently a Top ETF Choice?
101 finance2026-03-02 12:24:45
Should you consider adding the SPDR Dow Jones Industrial Average ETF (DIA) to your investment portfolio?
101 finance2026-03-02 12:28:07
Aaon: Fourth Quarter Financial Results Overview
101 finance2026-03-02 12:30:16
Palvella Therapeutics Announces Closing of Upsized Public Offering of Common Stock and Exercise in Full of the Underwriters' Option to Purchase Additional Shares
Finviz2026-03-02 12:33:44
Dyne Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Business Highlights
Finviz2026-03-02 12:33:45
Xanadu and Crane Harbor Announce SEC Declaration of Effectiveness of Form F-4 Registration Statement
Finviz2026-03-02 12:33:45
Biotechnology company Intellia Therapeutics announced that the U.S. Food and Drug Administration (FDA) has lifted the clinical hold on its Phase 3 Magnitude trial for transthyretin amyloid cardiomyopathy (ATTR-CM).
老虎证券2026-03-02 12:41:06
3 Stocks We’re Avoiding Right Now
101 finance2026-03-02 12:42:49
JPMorgan optimistic about buying opportunities during stock market pullbacks; oil price premium unlikely to last
格隆汇2026-03-02 12:52:04
Lifeward Announces Collaboration With Shirley Ryan AbilityLab to Expand Access for the ReWalk Personal Exoskeleton
Finviz2026-03-02 13:03:58
Top Dividend Stocks to Consider Purchasing on March 2nd
101 finance2026-03-02 13:03:45
Monopar Expands Leadership Team with Appointment of Seasoned Biopharma Executive Susan Rodriguez as Chief Commercial and Strategy Officer
Finviz2026-03-02 13:03:55
Picard Medical / SynCardia Showcases Leadership in Total Artificial Heart Therapy at Technology and Heart Failure Therapeutics Conference
Finviz2026-03-02 13:03:56
Wearable Devices to Debut Mudra Experience Studio, Expanding Neural Input into a Scalable AI Development Platform at MWC Barcelona 2026
Finviz2026-03-02 13:04:01
Nautilus Biotechnology Appoints Proteomics Commercial Leader Amber Faust as Vice President of Sales
Finviz2026-03-02 13:03:58
Cadrenal Therapeutics Highlights Recent 12-LOX Inhibitor Platform Expansion
Finviz2026-03-02 13:03:56
NVIDIA and Coherent Announce Strategic Partnership to Develop Optics Technology to Scale Next-Generation Data Center Architecture
Finviz2026-03-02 13:03:57
Nvidia to invest $4 billion in photonic product makers Lumentum and Coherent
101 finance2026-03-02 13:18:22
Zymeworks Inc. (ZYME) Posts Fourth Quarter Loss, Falls Short of Revenue Projections
101 finance2026-03-02 13:18:44
Is Xtrackers Russell US Multifactor ETF (DEUS) Currently a Top ETF Choice?
101 finance2026-03-02 12:24:41
Is First Trust Multi Cap Growth AlphaDEX ETF (FAD) Currently a Top ETF Choice?
101 finance2026-03-02 12:24:45
Should you consider adding the SPDR Dow Jones Industrial Average ETF (DIA) to your investment portfolio?
101 finance2026-03-02 12:28:07
Aaon: Fourth Quarter Financial Results Overview
101 finance2026-03-02 12:30:16
Palvella Therapeutics Announces Closing of Upsized Public Offering of Common Stock and Exercise in Full of the Underwriters' Option to Purchase Additional Shares
Finviz2026-03-02 12:33:44
Dyne Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Business Highlights
Finviz2026-03-02 12:33:45
Xanadu and Crane Harbor Announce SEC Declaration of Effectiveness of Form F-4 Registration Statement
Finviz2026-03-02 12:33:45
Biotechnology company Intellia Therapeutics announced that the U.S. Food and Drug Administration (FDA) has lifted the clinical hold on its Phase 3 Magnitude trial for transthyretin amyloid cardiomyopathy (ATTR-CM).
老虎证券2026-03-02 12:41:06
3 Stocks We’re Avoiding Right Now
101 finance2026-03-02 12:42:49
JPMorgan optimistic about buying opportunities during stock market pullbacks; oil price premium unlikely to last
格隆汇2026-03-02 12:52:04
Lifeward Announces Collaboration With Shirley Ryan AbilityLab to Expand Access for the ReWalk Personal Exoskeleton
Finviz2026-03-02 13:03:58
Top Dividend Stocks to Consider Purchasing on March 2nd
101 finance2026-03-02 13:03:45
Monopar Expands Leadership Team with Appointment of Seasoned Biopharma Executive Susan Rodriguez as Chief Commercial and Strategy Officer
Finviz2026-03-02 13:03:55
Picard Medical / SynCardia Showcases Leadership in Total Artificial Heart Therapy at Technology and Heart Failure Therapeutics Conference
Finviz2026-03-02 13:03:56
Wearable Devices to Debut Mudra Experience Studio, Expanding Neural Input into a Scalable AI Development Platform at MWC Barcelona 2026
Finviz2026-03-02 13:04:01
Nautilus Biotechnology Appoints Proteomics Commercial Leader Amber Faust as Vice President of Sales
Finviz2026-03-02 13:03:58
Cadrenal Therapeutics Highlights Recent 12-LOX Inhibitor Platform Expansion
Finviz2026-03-02 13:03:56
NVIDIA and Coherent Announce Strategic Partnership to Develop Optics Technology to Scale Next-Generation Data Center Architecture
Finviz2026-03-02 13:03:57
Nvidia to invest $4 billion in photonic product makers Lumentum and Coherent
101 finance2026-03-02 13:18:22
Zymeworks Inc. (ZYME) Posts Fourth Quarter Loss, Falls Short of Revenue Projections
101 finance2026-03-02 13:18:44
RSSS stock chart
RSSS stock detailsRSSS stock price change
On the last trading day, RSSS stock closed at 2.32 USD, with a price change of -2.52% for the day.
Trade stock perpsAbout Bitget
The world's first Universal Exchange (UEX), enabling users to trade not only cryptocurrencies, but also stocks, ETFs, forex, gold, and real-world assets (RWA).
Learn more